Workflow
THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies
Globenewswire· 2025-06-24 20:30
Breakthrough Transaction Unites Segment Leaders into a Powerful and Flexible Player in the Legal Cannabis IndustryMEDFORD, Ore., June 24, 2025 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the emerging and dynamic legal and regulated cannabis industry, announced today that it has acquired all of the issued and outstanding ownership interests of The Headquarters Group, Inc. (“THG”) in an all-share transaction valued at approximately $11,000,000 (the " ...
CVR Partners 2024 Schedule K-3 Now Available
Globenewswire· 2025-06-24 20:30
A limited number of investors (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on the Schedule K-3 for their specific reporting requirements. To the extent the Schedule K-3 is applicable to a unitholder's federal income tax return filing needs, unitholders are encouraged to review the information contained on this form and refer to the appropriate federal laws or co ...
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
Globenewswire· 2025-06-24 20:30
NEWPORT BEACH, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (the "Company," "PMGC," "we," or "us"), a diversified public holding company, today announced that it has entered into a non-binding Letter of Intent ("LOI") to acquire a U.S.-based, CNC machining company specializing in manufacturing high-complexity components for the aerospace and defense sectors. "This company exemplifies the kind of certified, mission-critical supplier we aim to partner with," said Graydon Bensler ...
Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation
Globenewswire· 2025-06-24 20:30
--During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study; on average, enobosarm 3mg significantly reduced body weight regain by 46% and completely prevented fat regain compared to placebo-- --The enobosarm treated groups showed up to 93% greater fat loss and 100% lean mass preservation compared to the placebo group at the end of the study-- --Enobosarm monotherapy had ...
DeFi Dev Corp. and dogwifhat Unleash Validator Partnership to Help Power Solana’s Future
Globenewswire· 2025-06-24 20:30
BOCA RATON, FL, June 24, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company") the first public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced a strategic validator partnership with the dogwifhat (WIF) community, one of the most iconic and culturally significant memecoin ecosystems on Solana. Under this partnership, DeFi Dev Corp. will operate a dedicated dogwifhat validator node on the Solana blockchain. The validator will be owned ...
TerraZero Technologies Launches Wave of Groundbreaking Artist Activations, Introducing New Firsts in Intraverse Music Experiences
Globenewswire· 2025-06-24 20:30
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce that TerraZero Technologies’ Intraverse is redefining what it means to be an artist in the digital age. Today, the company announces a new wave of music activations across its immersive platform—each a milestone not jus ...
Premier Air Charter, Inc. Announces The Appointment of Vincent Monteparte as Chairman of the Board of Directors
Globenewswire· 2025-06-24 20:30
Regarding his appointment as Chairman of the Board, Mr. Monteparte commented: "I'm honored to join Premier Air Charter as Chairman of the Board. The company is uniquely positioned in a high-growth market, and I look forward to working closely with the leadership team to accelerate innovation, drive operational excellence, and unlock long-term value for our shareholders and customers. About Premier Air Charter Vincent Monteparte Named Premier's Chairman of the Board of Directors CARLSBAD, Calif., June 24, 20 ...
National MI Earns Trio of Great Place to Work Distinctions
Globenewswire· 2025-06-24 20:30
文章核心观点 - 国家抵押保险公司(National MI)获得三项公司文化奖项,体现其良好的企业文化和员工体验 [1][2] 公司获奖情况 - 公司获2025年“最佳工作场所”称号,连续十年获此荣誉获“十年卓越”殊荣 [2] - 公司在《财富》杂志评选的湾区最佳工作场所中排名第22位 [2] 公司领导表态 - 公司总裁兼首席执行官亚当·波利策表示员工是持续成功的关键,公司旨在以影响力引领并实现组织使命 [3] - 公司首席人力资源官艾莉森·米勒称公司致力于让员工塑造工作体验,荣誉反映团队努力和对公司的信心 [5] 员工评价 - 今年96%的员工认可公司为最佳工作场所,比美国公司平均水平高39个百分点 [3] - 员工在优质客户服务、新员工友好环境、鼓励平衡工作与生活、鼓励创新等方面给公司高分 [8] 评选相关信息 - 《财富》杂志评选湾区最佳工作场所调查了美国130万员工,近8.5万份来自符合2025年评选资格的公司员工 [9] - 公司需获“最佳工作场所认证”、至少10名美国员工且总部在湾区才有资格参选 [9] 评选机构介绍 - Great Place To Work是全球职场文化权威机构,有三十多年研究和数据,其平台和模型可评估员工体验 [11] - “最佳工作场所认证”是公司渴望获得的“首选雇主”认可,完全基于员工对工作场所体验的反馈 [10]
VREMT Presents Navitas with ‘Outstanding Technical Collaboration Award'
Globenewswire· 2025-06-24 20:30
文章核心观点 - 纳微半导体获吉利子公司VREMT颁发的“杰出技术合作奖”,其氮化镓和碳化硅解决方案助力电动汽车行业发展 [1][5] 获奖情况 - 纳微半导体获吉利子公司VREMT颁发的“杰出技术合作奖” [1] 合作成果 - 纳微与VREMT开设联合研发实验室,用GaNFast功率集成电路和GeneSiC功率MOSFET加速电动汽车动力系统开发,推动技术突破和高压电动汽车系统快速部署 [2] 产品进展 - 纳微推出行业首个采用HV - T2PaK顶侧冷却封装的汽车级“AEC - Plus”合格碳化硅MOSFET,满足严苛应用系统寿命要求,最新一代产品爬电距离达6.45毫米,符合高达1200V应用的IEC标准 [3] - 2025年4月推出达到AEC - Q100和AEC - Q101认证的汽车级GaNSafe™集成电路,集成多种功能,具备高可靠性和安全性 [4] 公司表态 - 纳微亚太区高级副总裁兼总经理表示该奖项证明公司技术领先及对电动汽车行业的承诺,其氮化镓和碳化硅解决方案可赋能极氪、沃尔沃和smart等车企,公司将继续推动创新与合作 [5] 公司介绍 - 纳微半导体是唯一纯业务、下一代功率半导体公司,2014年成立,庆祝功率创新10周年,拥有GaNFast™功率集成电路和GeneSiC™功率器件,专注多个市场,有超300项专利,提供20年GaNFast质保,是全球首个获碳中和认证的半导体公司 [6]
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
Globenewswire· 2025-06-24 20:30
ASHBURN, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the Company’s lead asset, QRX003, for the treatment of Netherton Syndrome. The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserve ...